| Apoptotic signals at the endoplasmic reticulum-mitochondria interface F Giamogante, E Poggio, L Barazzuol, A Covallero, T Calì Advances in protein chemistry and structural biology 126, 307-343, 2021 | 24 | 2021 |
| Angiotensin II promotes SARS-CoV-2 Infection via upregulation of ACE2 in human bronchial cells I Caputo, B Caroccia, I Frasson, E Poggio, S Zamberlan, M Morpurgo, ... International Journal of Molecular Sciences 23 (9), 5125, 2022 | 21 | 2022 |
| Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M E Poggio, F Vallese, AJW Hartel, TJ Morgenstern, SA Kanner, O Rauh, ... Cell Death & Disease 14 (4), 297, 2023 | 16 | 2023 |
| ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures E Poggio, L Barazzuol, A Salmaso, C Milani, A Deligiannopoulou, ... Genetics in Medicine 25 (12), 100971, 2023 | 9 | 2023 |
| SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA S Germani, AT Van Ho, A Cherubini, E Varone, A Chernorudskiy, ... Cell Reports Medicine 5 (3), 2024 | 8 | 2024 |
| Bitopic sigma 1 receptor modulators to shed light on molecular mechanisms underpinning ligand binding and receptor oligomerization G Rossino, M Rui, P Linciano, D Rossi, M Boiocchi, M Peviani, E Poggio, ... Journal of Medicinal Chemistry 64 (20), 14997-15016, 2021 | 8 | 2021 |
| Ca2+ signalling: A common language for organelles crosstalk in Parkinson's disease C Peggion, L Barazzuol, E Poggio, T Calì, M Brini Cell Calcium 115, 102783, 2023 | 7 | 2023 |
| Get Closer to the World of Contact Sites: A Beginner's Guide to Proximity-Driven Fluorescent Probes E Poggio, M Brini, T Calì Contact 5, 25152564221135748, 2022 | 5 | 2022 |
| A SPLICS reporter reveals α-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation F Giamogante, L Barazzuol, F Maiorca, E Poggio, A Esposito, A Masato, ... Nature Communications 15 (1), 1516, 2024 | 4 | 2024 |
| Discovery of RC-752, a Novel Sigma-1 receptor antagonist with antinociceptive activity: a promising tool for fighting neuropathic pain G Rossino, A Marra, R Listro, M Peviani, E Poggio, D Curti, G Pellavio, ... Pharmaceuticals 16 (7), 962, 2023 | 4 | 2023 |
| Stable integration of inducible SPLICS reporters enables spatio-temporal analysis of multiple organelle contact sites upon modulation of cholesterol traffic F Giamogante, L Barazzuol, E Poggio, M Tromboni, M Brini, T Calì Cells 11 (10), 1643, 2022 | 3 | 2022 |
| The ataxia-linked E1081Q mutation affects the sub-plasma membrane Ca2+-microdomains by tuning PMCA3 activity F Vallese, L Maso, F Giamogante, E Poggio, L Barazzuol, A Salmaso, ... Cell Death & Disease 13 (10), 855, 2022 | 1 | 2022 |
| 702P SEPN1/SELENON-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA A Ferreiro, S Germani, AT Van Ho, A Cherubini, E Varone, ... Neuromuscular Disorders 43, 104441.196, 2024 | | 2024 |
| The enigmatic Sigma-1 Receptor: oligomeric states and potential therapeutic relevance.(L'enigmatico recettore Sigma-1: stati oligomerici e potenziale rilevanza terapeutica.) E POGGIO | | 2018 |
